Učitavanje...
Switching to aripiprazole for the treatment of residual mutism resulted in distinct clinical courses in two catatonic schizophrenia cases
OBJECTIVES: The efficacy of a partial agonist for the dopamine D(2) receptor, aripiprazole, for catatonia in schizophrenia has been reported. METHODS: We report distinct clinical courses in challenging aripiprazole to treat residual mutism after severe catatonic symptoms improved. RESULTS: In the fi...
Spremljeno u:
| Izdano u: | SAGE Open Med Case Rep |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5315413/ https://ncbi.nlm.nih.gov/pubmed/28255444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X17692936 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|